Quốc gia: Vương quốc Anh
Ngôn ngữ: Tiếng Anh
Nguồn: MHRA (Medicines & Healthcare Products Regulatory Agency)
Chlorquinaldol; Hydrocortisone butyrate
Astellas Pharma Ltd
D07BB04
Chlorquinaldol; Hydrocortisone butyrate
30mg/1gram ; 1mg/1gram
Cutaneous cream
Cutaneous
No Controlled Drug Status
Valid as a prescribable product
BNF: 13040000
IAT001-00 (LFT293) Page 1+2, 145 x 270 mm 145 mm 270 mm Insert 145 x 270 mm IAT001-00 15/08/2016 JUG 100% Used for: Comments: 059659-XX READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor, pharmacist or nurse. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Locoid Cream is and what it is used for 2. What you need to know before you use Locoid Cream 3. How to use Locoid Cream 4. Possible side effects 5. How to store Locoid Cream 6. Contents of the pack and other information 1. WHAT LOCOID CREAM IS AND WHAT IT IS USED FOR Locoid Cream contains the active substance hydrocortisone butyrate. This is a corticosteroid which when made up as a cream is for use on the skin. This is known as topical application. Topical corticosteroids are ranked as mildly potent, moderately potent, potent and very potent; Locoid Cream is classed as potent. Topical corticosteroids are able to reduce the inflammation caused by a variety of skin conditions, and so allow it to get better. They can also affect the cause of the condition, which can lead to its healing. Locoid Cream is indicated in adults, children and infants. It is used to treat a variety of skin conditions that respond to topical corticosteroids. Among these are eczema and dermatitis (itching) of all types including atopic (childhood) eczema, photodermatitis (itching caused by exposure to light) and dermatitis caused by skin irritants and allergies. It can also be used in the treatment of psoriasis, a condition resulting in thickening of areas of the skin. It is important that you follow your doctor’s instru Đọc toàn bộ tài liệu
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Locoid cream 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Locoid Cream contains 0.1% w/w hydrocortisone butyrate. Excipient(s) with known effect: Cetostearyl alcohol (7.2% w/w) Butyl parahydroxybenzoate (0.05% w/w) Propyl parahydroxybenzoate (0.1% w/w) For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Cream. The product is a white to practically white cream. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Locoid Cream is indicated in adults, children and infants. The product is recommended for clinical use in the treatment of conditions responsive to topical corticosteroids e.g. eczema, dermatitis and psoriasis. Topical corticosteroids are not generally indicated in psoriasis but may be acceptable in psoriasis excluding widespread plaque psoriasis provided warnings are given, see section 4.4 Special warnings and precautions for use. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Adults and older people _ The same dose is used for adults and older people, as clinical evidence would indicate that no special dosage regimen is necessary in older people. _Paediatric population _ Long term treatment should be avoided where possible. _Infants _ Therapy should be limited if possible to a maximum of seven days. Method of administration For cutaneous use. Dosage: To be applied evenly and sparingly no more than twice daily. Application may be made under occlusion in the more resistant lesions such as thickened psoriatic plaques on elbows and knees. 4.3 CONTRAINDICATIONS Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. This preparation is contraindicated in the presence of untreated viral or fungal infections, tubercular or syphilitic lesions, peri-oral dermatitis, acne vulgaris and rosacea and in bacterial infections unless used in connection with appropriate chemotherapy. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Application under occlusion should be restricted to dermatoses involving Đọc toàn bộ tài liệu